| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-10 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0001 |